Breaking Finance News

Merck (ETR:MRK) target price raised to 114.00EUR, issued a report today by BNP PARIBAS

Yesterday Merck (ETR:MRK) traded 0.81% higher at 95.86EUR. The company’s 50-day moving average is 62.76EUR and its 200-day moving average is 58.03EUR. The last stock close price is up 7.55% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 13,605,282 shares of the stock were exchanged, up from an average trading volume of 9,682,570

Merck (ETR:MRK) had its target price raised to 114.00EUR by BNP PARIBAS in a report released 10/02/2016. The new target price indicates a possible upside of 0.19% based on the company's last stock close price.

Previously on 10/1/2016, BNP PARIBAS reported about Merck (ETR:MRK) raised the target price from 0.00EUR to 114.00EUR. At the time, this indicated a possible upside of 0.19%.

See Chart Below

Merck (ETR:MRK)

With a total market value of 0 EUR, Merck has 52 week low of 47.97EUR and a 52 week high of 64.00EUR with a PE ratio of 34.23 .

In addition to BNP PARIBAS reporting its target price, a total of 20 analysts have released a report on MRK. The one year target is 61.60EUR with two firms rating the stock a strong buy, 7 brokers rating the stock a buy, thirteen equity analysts rating the stock a hold, 0 analysts rating the company a underperform, and lastly 0 brokers rating the stock a sell.

General Company Details For Merck (ETR:MRK)

Merck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company diversifies its activities into four business divisions: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of chemical and biotechnological origin. The Consumer Health division comprises the over-the-counter products for preventive health care and self-treatment of minor ailments. The Merck Serono and Consumer Health divisions form together the Company's Pharmaceutical business sector. The Merck Millipore division comprises the activities of the Millipore Corporation. The Performance Materials division consists mainly of the Liquid Crystals and Pigments & Cosmetics business units. The Company operates through numerous subsidiaries, including Peer+ BV, AZ Electronic Materials (AZ) and Ormet Circuits Inc., a material supplier for the semiconductor industry.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *